Anticoagulant use in nonvalvular atrial fibrillation: Determining risk and choosing the safest course

Postgraduate Medicine

Volumn 108, Issue 2, 2000, Pages 113-126

  Gornick, Charles C ^a,b,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO; WARFARIN;

AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; PROTHROMBIN TIME; RISK ASSESSMENT; RISK FACTOR; STROKE;

EID: 0033840640     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2000.08.1185     Document Type: Article

References (34)

1. Atrial fibrillation
2. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: The Copenhagen AFASAK Study
3. Preliminary report of the Stroke Prevention in Atrial Fibrillation Study
4. Prevention in Atrial Fibrillation Study: Final results
5. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation
6. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study
7. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation
8. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials
9. The efficacy of aspirin in patients with atrial fibrillation: Analysis of pooled data from 3 randomized trials
10. Secondary prevention in nonrheumatic atrial fibrillation after transient ischaemic attack or minor stroke
11. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study
12. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study
13. Bleeding during antithrombotic therapy in patients with atrial fibrillation
14. The risk for and severity of bleeding complications in elderly patients treated with warfarin
15. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial
16. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation
17. Risk factors for intracranial hemorrhage in outpatients taking warfarin
18. Optimal oral anticoagulation therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia
19. Low doses of aspirin in stroke prevention
20. Echocardiographic predictors of stroke in patients with atrial fibrillation: A prospective study of 1 066 patients from 3 clinical trials
21. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation
22. How useful is thyroid function testing in patients with recent-onset atrial fibrillation?
23. Thyrotoxicosis, atrial fibrillation, and embolism, revisited
24. New method for terminating cardiac arrhythmias: Use of synchronized capacitor discharge
25. The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation
26. Return of atrial mechanical function following electrical cardioversion of atrial dysrhythmias
27. Atrial fibrillation follow-up investigation of rhythm management - The AFFIRM study design
28. The management of chronic atrial fibrillation: Indications and method of conversion to sinus rhythm
29. Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours
30. Transesophageal echocardiography facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: Final results of a prospective 4.5 year study
31. Cerebral thromboembolization after cardioversion of atrial fibrillation in patients without transesophageal echocardiographic findings of left atrial thrombus
32. Cardioversion guided by transesophageal echocardiography: The ACUTE Pilot Study. A randomized, controlled trial
33. Antithrombotic therapy in atrial fibrillation
34. Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation